Marketing

TREATMENT.COM AI INC. EXTENDS TERM OF MARKETING SERVICES PROVIDED BY I2I MARKETING GROUP

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES March 14, 2025…

1 day ago

2X Invests in AI-Enabled Marketing Solutions Through Strategic Partnership with Copy.ai

MALVERN, Pa., Feb. 18, 2025 (GLOBE NEWSWIRE) -- 2X, a leading provider of marketing as a service (MaaS), today announced…

4 weeks ago

ONE Advertising and Communication Services Ltd. Wins Gold for ‘Khate Raho Khushi Se’ Campaign at Adgully’s Marketing & Advertising Awards 2025

NEW DELHI, Feb. 14, 2025 /PRNewswire/ -- ONE Advertising and Communication Services Ltd. has been honoured with a Gold Award for…

4 weeks ago

Valneva Receives Marketing Authorization in the UK for the Worlds First Chikungunya Vaccine, IXCHIQ

Saint Herblain (France), February 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

1 month ago

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement…

2 months ago

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement…

2 months ago

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement…

2 months ago

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

Back to media releasesNext media release LONDON, Jan. 7, 2025 /PRNewswire/ -- Norgine today announced that it completed its marketing…

2 months ago

Button and The Shelf Partner to Unleash Unprecedented Product Level Purchase Data to Fuel New Budgets into the Creator Marketing Universe

NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Button, the leader in mobile commerce optimization, today announced a strategic partnership…

3 months ago

Maropost unveils AI-powered email marketing features that boost conversions for commerce brands

TORONTO, Dec. 6, 2024 /PRNewswire/ -- Maropost, the connected commerce platform revolutionizing mid-market merchant operations, today announced two groundbreaking AI-driven…

3 months ago